Skip Navigation


IJE Advance Access originally published online on October 1, 2004
International Journal of Epidemiology 2004 33(6):1404-1405; doi:10.1093/ije/dyh238
This Article
Right arrow Extract Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
33/6/1404-a    most recent
dyh238v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Baines, C. J
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Baines, C. J
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

IJE vol.33 no.6 © International Epidemiological Association 2004; all rights reserved.

Letters to the Editor

In search of the best available version of the truth

Cornelia J Baines

12 Queen's Park Cres. West, Room 401 C, Toronto, ON M5S 1A8, Canada. E-mail: cornelia.baines{at}utoronto.ca

Sirs—In their qualitative assessment of screening trials Freedman et al.1 demonstrate that impressive author affiliations and the peer review process do not guarantee accuracy. On page 50, the reader will find the following persuasive statement about the Canadian National Breast Screening Study (CNBSS). ‘Centre radiologists only agreed with the reference radiologist 30–50% of the time.’ What a dreadful study that must have been! Quite wrong.

The numbers they cite are clearly reported as kappa statistics, which indicate how much of the agreement observed was agreement beyond that which might occur by chance.2 In fact, Table 2 (which they disregarded) from our publication reveals very clearly that there was agreement between centre radiologists and the reference radiologist 85.6% of the time with respect to cancer cases and 75.8% of the time for mammograms from women who did not have cancer. Do these authors truly not understand the difference between inter-observer agreement and kappa statistics?

They go on to condemn the Canadian study for false negative mammograms. ‘Observer error and technical problems led to delayed detection in 22–35% of cancers.’ Our paper reports that the overall false negative rate was 24%: 22% for screen cancers and 35% for interval cancers; by not differentiating between screen and interval cancers, a false impression is conveyed. Contrast those rates with words from the radiologist D Kopans who wrote of a clinical study, ‘this review confirms another well known phenomenon, namely the failure of even expert observers to perceive all abnormalities.’3 He continues that a radiological review discovered that 54% of cancer cases had been read as negative. Although more than twice the false negative rate in the CNBSS, somehow Dr Kopans found 54% acceptable. It was ‘inflated’ because the review was not blind.

Page 51 begins with an attribution to me which is uninterpretable (‘Baines notes that a comparison of advanced cancers detected by MA + PE in treatment to those detected by PE in control (19 to 5) is biased.’) and cannot be identified on page 3294 as is claimed. As for allegations about flawed mammography and subverted randomization, these are stale, unwarranted and have been responded to previously.4

Not only did the authors present false data but they also based their evaluation on CNBSS results published 12 years ago rather than results published in 2000 and 2002, Table II. This must compel any intelligent reader to question the validity of their conclusions. Unfortunately, it is not the first time, nor will it be the last, that false data about the CNBSS have been published.4

The authors acknowledge spending much time in consultation with Dr L Tabar of the Two-County trial, presumably to help them understand Swedish data. It is unfortunate that they did not make similar efforts to understand Canadian data.


    References
 Top
 References
 
1 Freedman DA, Petitti DB, Robins JM. Point-counterpoint. On the efficacy of screening for breast cancer. Int J Epidemiol 2004;33:43–55.[Abstract/Free Full Text]

2 Baines CJ, McFarlane DV, Miller AB. The role of the reference radiologist. Estimates of inter-observer agreement and potential delay in cancer detection in the National Breast Screening Study. Invest Radiol 1990;25:971–76.[Web of Science][Medline]

3 Kopans DB. Detecting breast cancer not visible by mammography (Editorial) J Natl Cancer Inst 1992;84:745–47.[Free Full Text]

4 Baines CJ. The Canadian National Breast Screening Study: a perspective on criticisms. Ann Intern Med 1994;120:326–34.[Abstract/Free Full Text]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?



This Article
Right arrow Extract Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
33/6/1404-a    most recent
dyh238v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Baines, C. J
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Baines, C. J
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?